The Week in Biopharma, Feb. 1-7

Contract Development and Manufacturing Organization (CDMO)

• Recipharm Acquires Portuguese CDMO to Bolster Biologics Offering (Portugal)
• CordenPharma Expands CDMO Capabilities (Germany)
• Glycotope Spins-out Service Business to Newly Formed Glycotope Spins-out Service Business to Newly Formed FyoniBio (Germany)
• Coriolis Pharma Opens New ATMP Formulation Development Facilities (Germany)
• PCI Pharma Services Expands Sterile Fill-Finish Capabilities (USA)
• APNAR Pharma Acquires New Jersey Based Aurex Laboratories (USA)
• PAI further bolsters its portfolio with the acquisition of Teligent Sterile Injectable and Topical products (USA)

Biopharma

• Nanoform Signs GMP Manufacturing Program with TargTex (Finland)
• Lilly Invests $1B in New Manufacturing Facility in NC (USA)
• Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc. (USA)
• Intellia Broadens CRISPR Capabilities with Pick Up of Rewrite Therapeutics (USA)
• BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A. (USA)

 Contract Research Organization (CRO) 

• Mission Bio Transfers Tapestri GMP-Ready CGT Assay to Avance Biosciences (USA)
• KCAS Bioanalytical and Biomarker Services, a Vitruvian Partners portfolio Company, announces acquisition of FlowMetric, LLC (USA)

Contract Manufacturing Organization (CMO)

• n-Lorem Foundation Partners with Argonaut Manufacturing Services (USA)